Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
German American Bancorp
GABC
$1.91B
| $1.98M | ﹤0.01% |
73,048
+5,749
| +9% | +$164K |
|
1877
MannKind Corp
MNKD
$1.22B
| $1.97M | ﹤0.01% |
477,645
-198,700
| -29% | -$893K |
|
1878
Silicon Laboratories
SLAB
$7.23B
| $1.97M | ﹤0.01% |
+16,998
| New | +$2.35M |
|
1879
iShares S&P 500 Value ETF
IVE
$49.6B
| $1.97M | ﹤0.01% |
12,800
-16,100
| -56% | -$2.6M |
|
1880
Marten Transport
MRTN
$1.22B
| $1.97M | ﹤0.01% |
99,707
+66,507
| +200% | +$1.41M |
|
1881
LivePerson
LPSN
$27.3M
| $1.96M | ﹤0.01% |
33,643
-10,410
| -24% | -$685K |
|
1882
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
| $1.96M | ﹤0.01% |
49,300
+29,900
| +154% | +$1.2M |
|
1883
Northeast Community Bancorp
NECB
$372M
| $1.96M | ﹤0.01% |
132,500
-8,300
| -6% | -$130K |
|
1884
Kodak
KODK
$937M
| $1.95M | ﹤0.01% |
464,045
+93,996
| +25% | +$460K |
|
1885
Cannae Holdings
CNNE
$649M
| $1.95M | ﹤0.01% |
104,700
-8,705
| -8% | -$172K |
|
1886
Vanguard Energy ETF
VDE
$9.83B
| $1.95M | ﹤0.01% |
15,400
+11,300
| +276% | +$1.38M |
|
1887
Equity Bancshares
EQBK
$1.06B
| $1.95M | ﹤0.01% |
80,900
-3,600
| -4% | -$90.4K |
|
1888
Grid Dynamics Holdings
GDYN
$616M
| $1.95M | ﹤0.01% |
159,800
+16,806
| +12% | +$186K |
|
1889
iShares S&P 100 ETF
OEF
$20.4B
| $1.95M | ﹤0.01% |
9,700
-3,000
| -24% | -$625K |
|
1890
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
| $1.95M | ﹤0.01% |
73,600
-4,700
| -6% | -$129K |
|
1891
iShares MSCI China ETF
MCHI
$6.28B
| $1.93M | ﹤0.01% |
+44,600
| New | +$2.02M |
|
|
ACLX
1892
DELISTED
Arcellx
ACLX
| $1.93M | ﹤0.01% |
53,800
-290,867
| -84% | -$10M |
|
1893
AMREP Corp
AXR
$119M
| $1.92M | ﹤0.01% |
114,400
+1,600
| +1% | +$27.9K |
|
1894
iShares Core S&P US Value ETF
IUSV
$27.5B
| $1.92M | ﹤0.01% |
25,700
-1,500
| -6% | -$118K |
|
|
DEN
1895
DELISTED
Denbury Inc.
DEN
| $1.91M | ﹤0.01% |
+19,500
| New | +$1.76M |
|
1896
Vanguard Morningstar Small-Cap ETF
VB
$81.5B
| $1.91M | ﹤0.01% |
+10,100
| New | +$2.01M |
|
|
PPBI
1897
DELISTED
Pacific Premier Bancorp
PPBI
| $1.91M | ﹤0.01% |
+87,728
| New | +$2.02M |
|
1898
Inovio Pharmaceuticals
INO
$68.7M
| $1.9M | ﹤0.01% |
407,458
-45,565
| -10% | -$252K |
|
1899
Xeris Biopharma Holdings
XERS
$1.25B
| $1.9M | ﹤0.01% |
1,022,040
+163,346
| +19% | +$374K |
|
1900
Tarsus Pharmaceuticals
TARS
$2.77B
| $1.9M | ﹤0.01% |
106,900
-7,600
| -7% | -$134K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.